US Stock MarketDetailed Quotes

Genmab (GMAB)

Watchlist
  • 28.250
  • -0.030-0.11%
Close Apr 10 16:00 ET
  • 27.800
  • -0.450-1.59%
Post 17:47 ET
18.15BMarket Cap18.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Genmab (GMAB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
DARZALEX2.44B65.67%
Kesimpta443M11.91%
Net product sales398M10.70%
Other111M2.98%
TEPEZZA105M2.82%
Milestone revenue97M2.61%
Collaboration revenue70M1.88%
Reimbursement revenue53M1.42%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark3.33B89.41%
Japan213M5.73%
United States180M4.84%
Netherlands1M0.03%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -